SSX8 antibody (C-Term)

Catalog No. ABIN928571

The Rabbit Polyclonal anti-SSX8 antibody has been validated for WB. It is suitable to detect SSX8 in samples from Human.

Quick Overview for SSX8 antibody (C-Term) (ABIN928571)

Target: SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SSX8 antibody is un-conjugated

Application: Western Blotting (WB)

Product Details anti-SSX8 Antibody

Binding Specificity: C-Term

Purification: Purified

Immunogen: SSX8 antibody was raised in rabbit using the C terminal of SSX8 as the immunogen

Application Details

Application Notes: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Comment:

SSX8 Blocking Peptide, (ABIN5616401), is also available for use as a blocking control in assays to test for specificity of this SSX8 antibody

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handling Advice: Avoid repeated freeze/thaw cycles.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Target Details for SSX8

Target: SSX8 (Synovial Sarcoma, X Breakpoint 8 (SSX8))

Alternative Name: SSX8

Background: SSX8 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. Synonyms: Polyclonal SSX8 antibody, Anti-SSX8 antibody, synovial sarcoma, X breakpoint 8 antibody.